Joe Glass, PhD, MSW, is an associate investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin–Madison School of Social Work.
Dr. Glass’ research seeks to understand how effective health care interventions for unhealthy alcohol and drug use can reach more people. His research seeks to answer these questions:
Much of Dr. Glass’ recent work, funded by the National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and Kaiser Permanente, is studying approaches for routinely using smartphone and web-based treatments for unhealthy alcohol and drug use in health care. After receiving an MSW from the University of Michigan, Dr. Glass spent three years as a social worker at the Veterans Affairs Ann Arbor Healthcare System. As a licensed clinical social worker in a large mental health clinic, he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders. Much of his research is driven by his clinical experiences, considering the many people struggling with both mental health difficulties and unhealthy substance use who have yet to receive addiction treatment.
Dr. Glass is an affiliate assistant professor of health services and of psychiatry and behavioral sciences, at the University of Washington.
Chen J, Glass JE, Bensley KM, Goldberg SB, Lehavot K, Williams EC. Racial/ethnic and gender differences in receipt of brief intervention among patients with unhealthy alcohol use in the U.S. Veterans Health Administration. J Subst Abuse Treat. 2020 Jul 15:108078. doi: 10.1016/j.jsat.2020.108078. Online ahead of print. PubMed
Oh BH, Glass J, Narita Z, Koyanagi A, Sinha S, Jacob L. Discrimination and multimorbidity among Black Americans: findings from the National Survey of American Life. J Racial Ethn Health Disparities. 2020 May 26. doi: 10.1007/s40615-020-00773-z. [Epub ahead of print]. PubMed
Fortuna KL, Muralidharan A, Goldstein CM, Venegas M, Glass JE, Brooks JM. Certified peer specialists' perspective of the barriers and facilitators to mobile health engagement. J Technol Behav Sci. 2020;5(4):318-323. doi: 10.1007/s41347-020-00138-7. Epub 2020 Apr 27. PubMed
Richards JE, Shortreed SM, Simon GE, Penfold RB, Glass JE, Ziebell R, Williams EC. Association between patterns of alcohol use and short-term risk of suicide attempt among patients with and without reported suicidal ideation. J Addict Med. 2020 Mar 5. doi: 10.1097/ADM.0000000000000637. [Epub ahead of print]. PubMed
Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJH, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter R, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA. Documented opioid use disorder and its treatment in primary care patients across six US health systems. J Subst Abuse Treat. 2020 Mar;112S:41-48. doi: 10.1016/j.jsat.2020.02.001. PubMed
Amy Lee describes how the LHS Program is helping KP Washington track and improve treatment for opioid use disorder.
Drs. Lapham and Bradley find frequency of cannabis use can be tied to other behavioral health patterns and needs.
Health Affairs blog, Mar 11, 2020